Echinacoside‑induced nitric oxide production in endothelial cells : Roles of androgen receptor and the PI3K‑Akt pathway

Echinacoside (ECH) is a natural compound with an endothelium‑dependent vasodilatory effect. Nitric oxide (NO) is an important vasorelaxant released from endothelial cells. In order to examine the molecular mechanism of ECH‑induced NO production in endothelial cells, the present study investigated the involvement of androgen receptor (AR) and the phosphatidylinositol 3‑kinase (PI3K)/protein kinase B (Akt) pathway in the phosphorylation of endothelial nitric oxide synthase (eNOS) in human umbilical vein endothelial cells (HUVECs). Using the fluorescent probe DAF‑FM, the production of NO was found to be significantly increased, and eNOS was phosphorylated at Ser1177 in a concentration‑​dependent manner under 0.01‑10 µM ECH treatment in HUVECs. In addition, NO production and eNOS phosphorylation induced by ECH were diminished when pretreated with the AR antagonist nilutamide, or when transfected with AR small interfering RNAs. Furthermore, the ECH‑induced phosphorylation of the Akt at Ser473 was abrogated by 5 µM wortmannin (a PI3K inhibitor). These data indicated that ECH stimulated NO production via the AR‑dependent activation of eNOS in HUVECs, and that the PI3K/Akt pathway may be involved in eNOS phosphorylation induced by ECH.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:45

Enthalten in:

International journal of molecular medicine - 45(2020), 4 vom: 28. Apr., Seite 1195-1202

Sprache:

Englisch

Beteiligte Personen:

Gu, Li [VerfasserIn]
Lian, Danhong [VerfasserIn]
Zheng, Yimei [VerfasserIn]
Zhou, Wei [VerfasserIn]
Gu, Jinlei [VerfasserIn]
Liu, Xin [VerfasserIn]

Links:

Volltext

Themen:

31C4KY9ESH
51G6I8B902
Androgen Receptor Antagonists
EC 2.7.11.1
Echinacoside
Glycosides
I04O1DT48T
Imidazolidines
Journal Article
Nilutamide
Nitric Oxide
Proto-Oncogene Proteins c-akt
Receptors, Androgen

Anmerkungen:

Date Completed 23.11.2020

Date Revised 23.11.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.3892/ijmm.2020.4476

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM305815512